CONMED Corporation Partners With the Musculoskeletal Transplant Foundation for Sports Medicine Applications (press release)
CONMED Corporation (NASDAQ: CNMD) and the Musculoskeletal Transplant Foundation (MTF), the world's largest tissue bank, have announced that CONMED's subsidiary, CONMED Linvatec, will serve as the exclusive world-wide marketing representative for MTF's sports medicine allograft tissues. Additionally, CONMED Linvatec will assume responsibility for the world-wide distribution of MTF's Cascade Platelet-Rich Plasma (PRP) product, which uses a patient's own blood components to aid in the healing process.
Sports medicine arthroscopy is CONMED's largest single product franchise, comprising approximately 40% of the Company's sales. CONMED is an industry leader, providing a full range of surgical solutions for the repair of soft tissue injuries usually caused by sports activities. MTF is dedicated to providing quality allograft tissue through a commitment to excellence in education, research, recovery, and care for recipients, donors and their families. It is a national consortium comprised of academic medical institutions, organ procurement organizatio...
